Full Text View
Tabular View
Study Results
Related Studies
Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis
This study has been completed.
Study NCT00462020   Information provided by Children's Mercy Hospital Kansas City

First Received on April 16, 2007.   Last Updated on December 12, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Perforated Appendicitis
Additional conditions recognized in this trial
Acute Disease
Appendicitis
More general conditions related to this trial
Cecal Diseases
Digestive System Diseases
Disease Attributes
Gastroenteritis
Gastrointestinal Diseases
Intestinal Diseases
Pathologic Processes
Additional drug interventions recognized in this trial
Ampicillin
Anti-Bacterial Agents
Ceftriaxone
Clavulanic Acid
Clavulanic Acids
Metronidazole
More general drug interventions related to this trial
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Children's Mercy Hospital Kansas City


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services